Project Grant R01DA061661

Award Date 7/15/24
Completion Date 4/30/29
Dollars Obligated $3.1M
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This Project Grant award of $606,924, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a 2-year research study entitled "CHAMPION - Combining HIV and Stimulant Prevention and Treatment Interventions Optimized for HIV-Negative MSM." The study aims to evaluate the feasibility, acceptability, and preliminary efficacy of a mobile health intervention package that combines a PrEP adherence app with virtual...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,681,276 to the Research Foundation of the City University of New York (RFCUNY) to conduct research on optimizing long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) strategies for sexual minority men (SMM) who use methamphetamine. The study aims to qualitatively identify modifiable care options for LAI PrEP use through rapid interviews,...
This $5.37 million project grant from the National Institutes of Health National Institute on Drug Abuse will fund the development of a context-aware digital adherence intervention called SMARTSTEPS to improve pre-exposure prophylaxis (PrEP) adherence among men who have sex with men with substance use disorder. The grant will support two phases. Phase I will inform the specification of an algorithm that utilizes digital phenotyping data from a smartphone app to anticipate non-adherence based...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $405,490 to the University of Georgia Research Foundation, Inc. to characterize chemsex patterns and the adoption of harm reduction measures among men in the southern United States. The key objectives of this 2-year project are to: (1) conduct in-depth interviews with 30 men to examine features of chemsex, such as drug use, sexual...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and assessment of a behavioral economic intervention to improve HIV-related behaviors among sexual minority men (SMM). The $264,091 award, effective September 15, 2024, aims to refine and evaluate the feasibility and acceptability of an Episodic Future Thinking (EFT) intervention delivered via smartphone to address delayed...
This federal Project Grant award of $1,422,000 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting the development and pilot testing of a mobile health (mHealth) intervention to reduce substance use and HIV risk among young adult women affected by sex trafficking. The project aims to adapt an existing mHealth intervention for this population, using qualitative and ecological momentary assessment methods to understand...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will provide $181,974 over 5 years to The Johns Hopkins University to conduct implementation science research optimizing HIV prevention and harm reduction services for men who have sex with men engaged in transactional sex in Baltimore, Maryland. The award will fund training and mentored research for the principal investigator, Dr. Atkins, to...
The federal Project Grant award of $1,272,602.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support the "Integrating U=U into HIV Counseling: A Cluster-Randomized Efficacy Trial (INTUIT 2.0)" research project. The study aims to (1) refine an educational "Undetectable & You" mobile app intervention designed to disseminate information on the prevention benefits of antiretroviral therapy (ART) and...
This $198,531 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to develop and pilot test an integrated intervention that addresses mental health and HIV medication adherence among men who have sex with men (MSM) in South Africa. The proposed "WECARE" intervention will be based on principles of problem-solving therapy, minority stress theory, and a status-neutral approach to target both mental...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $457,596 to The Trustees of the University of Pennsylvania to identify key engagement characteristics that can enhance the effectiveness of digital HIV interventions for at-risk youth. The project aims to: 1) harmonize engagement data across multiple Adolescent Medicine Trials Network for HIV Interventions (ATN) - UNC/Emory Center for Innovative...

OPTIMIZING A JUST-IN-TIME ADAPTIVE INTERVENTION TO INCREASE UPTAKE OF CHEMSEX HARM REDUCTION SERVICES IN MSM: A MICRO-RANDOMIZED TRIAL - ABSTRACT CHEMSEX, THE USE OF PSYCHOACTIVE DRUGS BEFORE OR DURING SEXUAL ACTIVITY, IS A GROWING PUBLIC HEALTH CONCERN DUE TO ITS ASSOCIATION WITH INCREASED HIV TRANSMISSION AND OTHER HARMS, PARTICULARLY AMONG MEN WHO HAVE SEX WITH MEN (MSM). CURRENT ESTIMATES SUGGEST THAT 9-26% OF MALAYSIAN MSM PARTICIPATE IN CHEMSEX, CONTRIBUTING TO RECENT INCREASES IN HIV PREVALENCE. IN THE ABSENCE OF EVIDENCE-BASED INTERVENTIONS FOR CHEMSEX, HARM REDUCTION STRATEGIES REMAIN THE MOST IMPACTFUL APPROACH TO MITIGATING CHEMSEX-ASSOCIATED HARMS. HOWEVER, GETTING HARM REDUCTION INTERVENTIONS TO MSM WHO ENGAGE IN CHEMSEX IS A MAJOR CHALLENGE DUE TO THE SPONTANEOUS AND DYNAMIC NATURE OF CHEMSEX RISK. JUST-IN-TIME ADAPTIVE INTERVENTIONS (JITAIS) DELIVERED VIA SMARTPHONES REPRESENT A POWERFUL STRATEGY TO DELIVER SUPPORT BY DEPLOYING TAILORED INTERVENTION WHEN NEEDED. SPECIFICALLY, APPS THAT INCORPORATE JITAI CAN BE MORE EFFECTIVE THAN TRADITIONAL APP-BASED INTERVENTIONS BY ADDRESSING THE DYNAMIC NATURE OF CHEMSEX RISK AND CAPITALIZING ON USERS' CHANGING STATES OF VULNERABILITY (HEIGHTENED CHEMSEX RISK BEHAVIORS) AND RECEPTIVITY (WILLINGNESS TO ENGAGE IN INTERVENTION), WHILE ALSO MINIMIZING USER BURDEN, DISRUPTION, AND HABITUATION. ALTHOUGH JITAIS ARE INCREASINGLY BEING USED IN DOMAINS SUCH AS ADDICTION, MENTAL HEALTH DISORDERS, PHYSICAL INACTIVITY, AND OBESITY, RESEARCH ON JITAIS TO ADDRESS CHEMSEX HARM REDUCTION IS NON-EXISTENT. IN RESPONSE, WE DEVELOPED JOMCARE, A SMARTPHONE APP-BASED CHEMSEX HARM REDUCTION JITAI, THAT USES A MACHINE LEARNING ALGORITHM TO DETERMINE RISK AND DELIVER TAILORED SUPPORT AS NEEDED. JOMCARE INCLUDES SEVERAL `PULL' AND `PUSH' INTERVENTION COMPONENTS BASED ON THE INFORMATION-MOTIVATION-BEHAVIORAL SKILLS (IMB) MODEL, AND HAS DEMONSTRATED HIGH FEASIBILITY AND UTILITY IN OUR RECENT PILOT WORK. HOWEVER, LITTLE IS KNOWN TO GUIDE WHICH INTERVENTION COMPONENTS SHOULD BE DELIVERED IN SPECIFIC CONTEXTS TO ACHIEVE MAXIMUM BENEFIT, THUS INDICATING THE NEED TO OPTIMIZE JOMCARE. FRAMED BY THE MULTIPHASE OPTIMIZATION STRATEGY (MOST) AND BUILDING ON OUR FORMATIVE WORK, WE WILL OPTIMIZE JOMCARE USING A MICRO-RANDOMIZED TRIAL (MRT) TO EVALUATE: I) WHICH THEORY-DRIVEN INTERVENTION COMPONENTS ARE EFFICACIOUS IN REDUCING CHEMSEX RISK BEHAVIORS; AND II) WHICH CONTEXTS INFLUENCE THE EFFICACY OF JOMCARE. SPECIFICALLY, WE WILL CONDUCT A 90-DAY MRT OF THE JOMCARE JITAI AMONG 482 CHEMSEX-INVOLVED MALAYSIAN MSM. PARTICIPANTS WILL BE RANDOMIZED TWICE DAILY VIA THE APP TO RECEIVE: I) NO PROMPT; II) A GENERIC ENGAGEMENT PROMPT; OR III) ONE OF THREE IMB MODEL-BASED ENGAGEMENT PROMPTS. THE SPECIFIC AIMS OF THIS APPLICATION INCLUDE: I) EVALUATE THE EFFECTS OF ANY INTERVENTION (I.E., THEORY-DRIVEN OR GENERIC ENGAGEMENT PROMPTS) VERSUS NO INTERVENTION ON CHEMSEX RISK BEHAVIORS (PROXIMAL OUTCOMES) AT SUBSEQUENT EMAS FOLLOWING RANDOMIZATION; II) COMPARE THE EFFECTS OF THEORY-DRIVEN AND GENERIC ENGAGEMENT PROMPTS ON PROXIMAL OUTCOMES; AND III) EXAMINE CONTEXTUAL MODERATORS OF INTERVENTION ON PROXIMAL OUTCOMES.

Posted 7/9/24, 12:00 AM